搜索筛选:
搜索耗时0.0866秒,为你在为你在102,285,761篇论文里面共找到 10 篇相符的论文内容
类      型:
[会议论文] 作者:Su Gao,Huiying Qiu,Zhengming Jin,Xiaowen Tang,Chengcheng Fu,Xiao Ma,Yue Han,Suning Chen,Aining Sun,Depei, 来源:The 35th World Congress of the International Society of Hema 年份:2014
[会议论文] 作者:Su Gao,Huiying Qiu,Zhengming Jin,Xiaowen Tang,Chengcheng Fu,Xiao Ma,Yue Han,Suning Chen,Aining Sun,Depei, 来源:The 35th World Congress of the International Society of Hema 年份:2014
[会议论文] 作者:Su Gao,Huiying Qiu,Zhengming Jin,Xiaowen Tang,Chengcheng Fu,Xiao Ma,Yue Han,Suning Chen,Aining Sun,Depei, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Objective To observe the clinical safety and efficacy of decitabine in patients of acute myeloid leukemia and myelodysplastic syndromes.Methods Totally 79 patients with MDS/AML were divided into three...
[会议论文] 作者:Su Gao,Huiying Qiu,Zhengming Jin,Xiaowen Tang,Chengcheng Fu,Xiao Ma,Yue Han,Suning Chen,Aining Sun,Depei, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Objective To detect the level of MDS / AML patients treated with decitabine and study the relationship between the level of DNA methylation in the tumor cells of MDS / AML and decitabine.To discuss th...
[会议论文] 作者:Jun Wang,Aining Sun,Shuo Yang,Huiying Qiu,Zhengming Jin,Xiaowen Tang,Yue Han,Zhengzheng Fu,Xiao Ma,Jia, 来源:The 35th World Congress of the International Society of Hema 年份:2014
HLA-mismatched/haploidentical transplantation for high-risk hematologic malignancies is associated with the increased risk of severe aGVHD,and poor overall survival (OS).We conducted a haploidentical...
[会议论文] 作者:Xiaojing Shi,Aining Sun,Xiaming Zhu,Huiying Qiu,Zhengming Jin,Miao Miao,Chengcheng Fu,Xiao Ma,Feng Chen, 来源:The 35th World Congress of the International Society of Hema 年份:2014
[会议论文] 作者:Hua Zhou,Ling Ge,Xiaming Zhu,Huiying Qiu,Zhengming Jin,Miao Miao,Chengcheng Fu,Xiao Ma,Feng Chen,Shengli, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Background Recurrence is a major cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute leukemia,and subsequential treatment options are very limited...
[会议论文] 作者:Xiaojing Shi,Aining Sun,Xiaming Zhu,Huiying Qiu,Zhengming Jin,Miao Miao,Chengcheng Fu,Xiao Ma,Feng Chen, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment options to hematologic malignancies.However,majority of patients with refractory or resistant h...
[会议论文] 作者:Ling Ge,Fan Ye,Jia Chen,Aining Sun,Xiaming Zhu,Huiying Qiu,Zhengming Jin,Miao Miao,Chengcheng Fu,Xiao, 来源:The 35th World Congress of the International Society of Hema 年份:2014
[会议论文] 作者:Ling Ge,Fan Ye,Xinliang Mao,Jia Chen,Aining Sun,Xiaming Zhu,Huiying Qiu,Zhengming Jin,Miao Miao,Chengcheng, 来源:The 35th World Congress of the International Society of Hema 年份:2014
Background Extramedullary relapse (EMR) of Acute Leukemia (AL) following allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a contributor to post-transplant mortality and remains poorly...
相关搜索: